**Question:** Which of the following factors do not result in increased risk of digitalis toxicity?

A. Age
B. Congestive Heart Failure (CHF)
C. Chronic Kidney Disease (CKD)
D. Atherosclerosis

**Core Concept:**
Digitalis is a group of cardiac glycosides derived from the foxglove plant, commonly used as a medication for heart failure. Digitalis works by inhibiting the sodium-potassium pump (Na+/K+-ATPase) in the cell membrane, leading to increased intracellular calcium levels, which results in enhanced contractility of the cardiac muscle. However, this increased contractility can lead to digitalis toxicity if not monitored carefully.

**Why the Correct Answer is Right:**
Option A, age, is not directly related to increased risk of digitalis toxicity. Although elderly patients may have a higher risk of adverse effects due to reduced renal clearance and altered pharmacokinetics, the presence of digitalis toxicity symptoms should still be monitored carefully regardless of age.

Option B, Congestive Heart Failure (CHF), is not a risk factor for digitalis toxicity but is rather a condition for which digitalis is commonly used. Monitoring of serum digitalis levels and clinical symptoms is essential in CHF patients to avoid toxicity.

Option C, Chronic Kidney Disease (CKD), is a risk factor for digitalis toxicity due to reduced renal clearance, leading to elevated blood levels of digitalis. Careful monitoring of serum digitalis levels and clinical symptoms is crucial in patients with CKD.

Option D, Atherosclerosis, is not directly related to increased risk of digitalis toxicity. However, patients with atherosclerosis may have compromised renal function, contributing to the risk of digitalis toxicity.

**Why Each Wrong Option is Incorrect:**
Option A (age) is incorrect because it is not a direct risk factor for digitalis toxicity.
Option B (Congestive Heart Failure) is incorrect as digitalis is commonly used in CHF patients, not a risk factor for toxicity.
Option D (Atherosclerosis) is incorrect because it is not a direct risk factor for digitalis toxicity. However, patients with atherosclerosis may have compromised renal function, which could contribute to increased risk of digitalis toxicity.

**Clinical Pearl:**
In patients receiving digitalis therapy, it is essential to monitor renal function and serum digitalis levels in those with CKD or risk factors like advanced age, CHF, and atherosclerosis. This will help ensure appropriate management of digitalis therapy and prevent potential toxicity.